Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

NKGen Biotech (NKGN) SEC Filings & 10K Form

→ The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad)
Free NKGN Stock Alerts
$1.12
-0.01 (-0.88%)
(As of 05/17/2024 08:54 PM ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media

Recent NKGen Biotech SEC Filings

Export to Excel
DateFilerForm TypeView
05/13/2024
3:54 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form S-1/A
05/13/2024
7:05 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
1:42 PM		METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SC 13G/A
04/29/2024
4:20 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-K/A
04/16/2024
2:07 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/11/2024
7:05 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
3:55 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…
03/15/2024
4:02 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:11 PM		Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:14 PM		Gagnon Pierre (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:16 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:19 PM		Kim Yong Man (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:20 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
12:05 PM		METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SC 13G
02/14/2024
5:28 AM		NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Radcliffe Capital Management, L.P. (Filed by)
Form SC 13G/A
02/12/2024
8:25 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2024
4:07 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
6:31 AM		ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SC 13G/A
01/22/2024
5:12 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
6:50 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:19 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:14 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
12:41 PM		NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
NKMAX Co., Ltd. (Filed by)
Form SC 13D/A
12/15/2023
8:02 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
NKMAX Co., Ltd. (Reporting)
Park Sangwoo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:44 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form S-1/A
12/07/2023
4:23 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
2:50 PM		Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
2:51 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
4:30 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form S-1/A
11/22/2023
4:53 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:55 PM		Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
3:36 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:39 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2023
7:05 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2023
7:05 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023
4:23 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K/A
10/19/2023
4:27 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/10/2023
4:01 PM		NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
NKMAX Co., Ltd. (Filed by)
Form SC 13D
10/10/2023
3:15 PM		Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/05/2023
4:12 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
5:10 AM		Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The Overlooked Retirement Asset You Probably Don’t Own (Ad)

4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.

Click here to access the Crypto Retirement Blueprint now.
09/29/2023
4:24 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
3:16 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form CERT
09/29/2023
2:11 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
11:03 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-A12B
09/22/2023
3:08 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 424B3
09/22/2023
11:55 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
11:55 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/22/2023
8:26 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
8:27 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/21/2023
6:31 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 424B3
09/19/2023
2:51 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
2:52 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/18/2023
8:25 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
8:26 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/14/2023
8:30 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
8:31 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/11/2023
10:30 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
10:30 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
08/30/2023
6:30 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
6:30 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
08/24/2023
7:15 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
08/15/2023
3:30 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2023
3:31 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
08/14/2023
11:15 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form EFFECT
08/10/2023
1:09 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form S-4/A
08/09/2023
1:05 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
07/26/2023
10:54 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2023
10:55 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
07/17/2023
7:00 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
7:00 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
07/17/2023
5:01 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form S-4/A
07/06/2023
11:34 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
06/27/2023
12:37 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
06/26/2023
4:02 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form S-4/A
06/05/2023
7:30 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:32 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
05/31/2023
8:45 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
8:46 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
05/23/2023
9:29 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Radcliffe Capital Management, L.P. (Filed by)
Form SC 13G
05/22/2023
8:03 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NYSE:NKGN) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
"The Biggest Drug Ever" Is Coming
Behind the Markets
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Elon’s New Device is About to Shock the World
InvestorPlace
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
Most important medical advance in 100 years
The Oxford Club